Details
Stereochemistry | MIXED |
Molecular Formula | C20H29NO2 |
Molecular Weight | 315.4498 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(COC1CN2CCC1CC2)(C3CCCC3)C4=CC=CC=C4
InChI
InChIKey=GTKRIWMDLNOSLI-UHFFFAOYSA-N
InChI=1S/C20H29NO2/c22-20(18-8-4-5-9-18,17-6-2-1-3-7-17)15-23-19-14-21-12-10-16(19)11-13-21/h1-3,6-7,16,18-19,22H,4-5,8-15H2
Penequinine (penehyclidine) is a selective M1/M2 receptor antagonist. Due to anticholinergic effects, penequinine is used in Chine for the treatment of organophosphorus and soman poisoning. In addition, penequinine is a negative regulator of TLR4 and NF-kB signaling and is investigated as a potential treatment in clinical trials for the treatment of acute lung injury and acute cerebral ischemia-reperfusion injury.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effects of pretreatment with 8018 on the toxicokinetics of soman in rabbits and distribution in mice. | 2003 Jul 11 |
|
Synthesis of the optical isomers of a new anticholinergic drug, penehyclidine hydrochloride (8018). | 2005 Apr 15 |
|
The pre- and post-natal toxicity of penequine hydrochloride in mice. | 2006 Nov |
|
Embryo-fetal development toxicity of prenatal exposure to penequine hydrochloride intramuscularly in rats. | 2007 Apr |
|
Fertility and early embryonic development toxicity of penequine hydrochloride in mice. | 2007 Jun |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
87827-02-9
Created by
admin on Sat Dec 16 11:21:40 GMT 2023 , Edited by admin on Sat Dec 16 11:21:40 GMT 2023
|
PRIMARY | |||
|
353CX8CSHD
Created by
admin on Sat Dec 16 11:21:40 GMT 2023 , Edited by admin on Sat Dec 16 11:21:40 GMT 2023
|
PRIMARY | |||
|
137356
Created by
admin on Sat Dec 16 11:21:40 GMT 2023 , Edited by admin on Sat Dec 16 11:21:40 GMT 2023
|
PRIMARY | |||
|
DTXSID30100781
Created by
admin on Sat Dec 16 11:21:40 GMT 2023 , Edited by admin on Sat Dec 16 11:21:40 GMT 2023
|
PRIMARY | |||
|
100000145086
Created by
admin on Sat Dec 16 11:21:40 GMT 2023 , Edited by admin on Sat Dec 16 11:21:40 GMT 2023
|
PRIMARY | |||
|
SUB122749
Created by
admin on Sat Dec 16 11:21:40 GMT 2023 , Edited by admin on Sat Dec 16 11:21:40 GMT 2023
|
PRIMARY |
ACTIVE MOIETY